NEWSROOM CATEGORY:
*Announcements

STM submission to NIH RFI on Allowable Publishing Costs
Cloudflare adds to their AI toolkit
The CDN provider has recently announced new tools and services for the era of AI. The two latest ones are their Content Signals Policy, which makes robots.txt indications more specific, and responsible AI bot principles. These may help bridge the gap between current practices and evolving legislation by providing effective tools to manage AI bots.
Research & Innovation Days in Brussels
Discussions at the R&I Days centred around the next EU funding programme for research (the successor of Horizon Europe), the new European Competitiveness Fund and the many unresolved questions about how their governance will work. A balance between funding for strategic investments, selected top-down, and blue-sky research (mainly funded through the ERC) will need to…
Upcoming EU initiatives
We’re expecting a busy autumn: after conducting consultations over the summer, the EU Commission will release a strategy for AI in science on 7 October and a Data Union Strategy at the end of October. A consultation was just launched on a Digital Omnibus, a package to review and streamline digital legislation to alleviate compliance burdens…
Danish working group on copyright and AI publishes recommendations
The Danish Ministry for Culture tasked a dedicated working group to explore questions about the interplay between AI and copyright. They delivered a very good set of recommendations, including recommendations on effective transparency in training data. EU countries will continue debating this topic into the fall, exploring potential solutions to favour AI licensing.
Claudia Russo takes on expanded leadership role in STM’s Public Affairs Team
We are delighted to share that Claudia Russo has been appointed Director of Public Affairs EU and Deputy Global Director Public Affairs at STM. Claudia has been an integral part of STM’s public affairs team since 2020, most recently as Senior Manager of Public Affairs EU. Her appointment is a recognition of her extraordinary work to…
New Scholarly Kitchen post: Classifying AI Use in Manuscript Preparation – A Recommendation
It is almost a cliché to say that AI has changed the academic publishing industry – for authors, reviewers, editors, readers, and publishers themselves. In 2023, STM published guidelines outlining ethical and practical considerations regarding the use of AI tools in the publication process. In the two years since, technology has progressed significantly, creating even more possibilities…
STM submits comments on upcoming ERA Act
The European Commission is planning an European Research Area (ERA) Act for Q3 2026, with the aim of further strengthening the European internal market for research and facilitating the free circulation of researchers and knowledge across EU countries. Measures not favourable for publishers (including Green OA measures such as the Secondary Publication Right) nor conducive…
EU Parliament resumes negotiations on AI & copyright
The EU Parliament’s Legal Affairs Committee is resuming discussions on its position on AI and copyright. Whilst not being a legislative instrument, this is quite important as it will provide political indications to the EU Commission. A draft was presented over the summer by MEP Axel Voss to get the conversation started. STM reached out…
AI Act implementation package
Three key documents were released over the summer for the implementation of the EU AI Act’s rules for providers of general-purpose AI models: The Code of Practice outlines voluntary measures regarding transparency, copyright and safety and security. These guidelines clarify the scope of the definition and obligations of providers. The standardised template provides a summary…
STM submits comment on NIH’s proposal to cap publisher fees
Along with many publishers and others in the research community, STM submitted a comment to NIH in response to their “Request for Information on Maximizing Research Funds by Limiting Allowable Publishing Costs” In addition to the submission, STM has and will continue to engage in dialogue with NIH, OSTP, OMB, and Congress on our concerns…